TargetMol

Cefditoren pivoxil

Product Code:
 
TAR-T1405
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T1405-10mg10mg£114.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1405-1mL1 mL * 10 mM (in DMSO)£119.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1405-25mg25mg£157.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1405-50mg50mg£185.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1405-100mg100mg£230.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1405-200mg200mg£266.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1405-500mg500mg£389.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Cefditoren Pivoxil is a semi-synthetic, broad-spectrum, beta-lactamase resistant, third-generation cephalosporin antibiotic with bactericidal activity.
CAS:
117467-28-4
Formula:
C25H28N6O7S3
Molecular Weight:
620.71
Pathway:
Microbiology/Virology
Purity:
0.973
SMILES:
CON=C(/C(=O)N[C@H]1[C@H]2SCC(C=C/c3scnc3C)=C(N2C1=O)C(=O)OCOC(=O)C(C)(C)C)c1csc(N)n1
Target:
Antibacterial; Antibiotic

References

1. Jones RN, et al. Diagn Microbiol Infect Dis, 1998, 31(4), 573-578. 2. Johnson DM, et al. Diagn Microbiol Infect Dis, 2000, 37(2), 99-105. 3. Felmingham D, et al. Drugs Exp Clin Res, 1994, 20(4), 127-147. 4. Balbisi EA, et al. Pharmacotherapy, 2002, 22(10), 1278-1293. 5. Meng Q, et al. Drug Metab Pharmacokinet, 2010, 25(4), 320-327.